宿主因素与疫苗效力：对 COVID-19 疫苗的启示。
Host factors and vaccine efficacy: Implications for COVID-19 vaccines.
机构信息
Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
出版信息
J Med Virol. 2022 Apr;94(4):1330-1335. doi: 10.1002/jmv.27485. Epub 2021 Dec 7.
Abstract
The efficacy of the vaccines varies between individuals and populations. The immunogenicity of the vaccine is influenced by various factors, including host factors. Previous studies have shown that host factors affect the effectiveness of vaccines, which may be true about COVID-19 vaccines. In this review, we evaluate the possible association of host factors with vaccine efficacy with a special focus on COVID-19 vaccines.
摘要
疫苗的效力在个体和人群之间有所差异。疫苗的免疫原性受多种因素影响，包括宿主因素。先前的研究表明，宿主因素会影响疫苗的有效性，这对于 COVID-19 疫苗来说可能也是如此。在这篇综述中，我们评估了宿主因素与疫苗效力的可能关联，特别关注 COVID-19 疫苗。
相似文献
1
Host factors and vaccine efficacy: Implications for COVID-19 vaccines.
J Med Virol. 2022 Apr;94(4):1330-1335. doi: 10.1002/jmv.27485. Epub 2021 Dec 7.
2
COVID-19 vaccine breakthrough infections.
Science. 2021 Dec 24;374(6575):1561-1562. doi: 10.1126/science.abl8487. Epub 2021 Dec 23.
3
Metabolic disorders, COVID-19 and vaccine-breakthrough infections.
Nat Rev Endocrinol. 2022 Feb;18(2):75-76. doi: 10.1038/s41574-021-00608-9.
4
SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges.
Pediatr Res. 2021 Nov;90(5):966-970. doi: 10.1038/s41390-021-01402-z. Epub 2021 Feb 24.
5
Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
N Engl J Med. 2021 Dec 16;385(25):e100. doi: 10.1056/NEJMe2119539.
6
COVID vaccine makers brace for a variant worse than Delta.
Nature. 2021 Oct;598(7882):552-553. doi: 10.1038/d41586-021-02854-3.
7
Audio Interview: Waning Immunity against SARS-CoV-2.
N Engl J Med. 2021 Dec 9;385(24):e99. doi: 10.1056/NEJMe2119211.
8
Evolution of SARS-CoV-2: A prediction on the lineages and vaccine effectiveness.
Travel Med Infect Dis. 2021 Mar-Apr;40:101983. doi: 10.1016/j.tmaid.2021.101983. Epub 2021 Feb 4.
9
Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern.
Front Immunol. 2021 Nov 25;12:732693. doi: 10.3389/fimmu.2021.732693. eCollection 2021.
10
Developing Immunity Testing for SARS-CoV-2 and Other Novel Vaccines-Correlates of Immunogenicity Parameters with Protection.
Viruses. 2022 Jan 20;14(2):196. doi: 10.3390/v14020196.
引用本文的文献
1
Impact of vaccination and SARS-CoV-2 variants on severe COVID-19 outcomes: a cross-sectional study, Brazil, 2021-2022.
Epidemiol Serv Saude. 2025 Sep 1;34:e20240613. doi: 10.1590/S2237-96222025v34e20240613.en. eCollection 2025.
2
BCG and beyond: unlocking new frontiers in TB vaccine development.
Front Immunol. 2025 Jul 30;16:1608104. doi: 10.3389/fimmu.2025.1608104. eCollection 2025.
3
Immune Aging, Immunosenescence, and Inflammaging: Implications for Vaccine Response in Older Adults.
Health Sci Rep. 2025 Jul 23;8(7):e71119. doi: 10.1002/hsr2.71119. eCollection 2025 Jul.
4
The Possible Mechanistic Basis of Individual Susceptibility to Spike Protein Injury.
Adv Virol. 2025 Jun 24;2025:7990876. doi: 10.1155/av/7990876. eCollection 2025.
5
Comparative analysis of humoral immunity kinetics following three COVID-19 vaccines in a multi-ethnic cohort of medical students and healthcare professionals across Malaysia.
Sci Rep. 2025 Jul 1;15(1):21953. doi: 10.1038/s41598-025-07895-6.
6
Tanzanian gut microbiota profiles linked to high but rapidly waning yellow fever antibody titers.
NPJ Biofilms Microbiomes. 2025 Jun 19;11(1):110. doi: 10.1038/s41522-025-00687-w.
7
Vaccination versus natural infection: A review of antibody differentiation techniques.
J Res Med Sci. 2025 Mar 29;30:18. doi: 10.4103/jrms.jrms_550_24. eCollection 2025.
8
Quantitative risk assessment and interventional recommendations for preventing canine distemper virus infection in captive tigers at selected wildlife stations in Thailand.
PLoS One. 2025 Apr 17;20(4):e0320657. doi: 10.1371/journal.pone.0320657. eCollection 2025.
9
Development of a personalized digital biomarker of vaccine-associated reactogenicity using wearable sensors and digital twin technology.
Commun Med (Lond). 2025 Apr 13;5(1):115. doi: 10.1038/s43856-025-00840-8.
10
Real-world COVID-19 vaccine effectiveness in Zimbabwe: A test-negative case-control study.
J Public Health Afr. 2025 Feb 19;16(1):695. doi: 10.4102/jphia.v16i1.695. eCollection 2025.
本文引用的文献
1
Humoral response after BNT162b2 mRNA COVID-19 vaccination in patients on haemodialysis depends on immune status.
Clin Kidney J. 2021 Jul 6;14(10):2266-2267. doi: 10.1093/ckj/sfab109. eCollection 2021 Oct.
2
Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
Vaccines (Basel). 2021 Jul 27;9(8):825. doi: 10.3390/vaccines9080825.
3
Impact of body mass index on immunogenicity of hepatitis B vaccine in bariatric surgery candidates: A retrospective study.
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102254. doi: 10.1016/j.dsx.2021.102254. Epub 2021 Aug 22.
4
Vaccine efficacy and iron deficiency: an intertwined pair?
Lancet Haematol. 2021 Sep;8(9):e666-e669. doi: 10.1016/S2352-3026(21)00201-5.
5
Antibody Responsiveness to Influenza: What Drives It?
Viruses. 2021 Jul 19;13(7):1400. doi: 10.3390/v13071400.
6
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.
Nature. 2021 Aug;596(7872):417-422. doi: 10.1038/s41586-021-03739-1. Epub 2021 Jun 30.
7
Nutrition and immunity: lessons for COVID-19.
Eur J Clin Nutr. 2021 Sep;75(9):1309-1318. doi: 10.1038/s41430-021-00949-8. Epub 2021 Jun 23.
8
Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2.
Clin J Am Soc Nephrol. 2021 Jul;16(7):1073-1082. doi: 10.2215/CJN.03700321. Epub 2021 May 24.
9
Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms.
Nat Rev Immunol. 2022 Jan;22(1):33-46. doi: 10.1038/s41577-021-00554-7. Epub 2021 May 17.
10
Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease.
Biol Sex Differ. 2021 May 17;12(1):35. doi: 10.1186/s13293-021-00378-z.
Zotero 插件